EGFR and non-small cell lung carcinoma: Moreover, combination treatment with the epidermal growth factor receptor (EGFR) inhibitor, erlotinib and miR-34 mimic and let-7 showed synergistic effects in inhibiting the growth of non-small cell lung cancer cell lines in vitro [177].